HyperCVAD Alternating with High-dose MTX AraC Regimen - CISMeF
HyperCVAD Alternating with High-dose MTX AraC RegimenNCIt concept
Preferred Label : HyperCVAD Alternating with High-dose MTX AraC Regimen;
NCIt synonyms : Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone/High-dose
Methotrexate-Cytarabine Regimen; Hyper-CVAD-HDMTX-AraC Regimen; HyperCVAD Alternating with Methotrexate/Cytarabine; HyperCVAD Alternating with High Dose Methotrexate and Cytarabine; HyperCVAD/MTX-Ara-C; HyperCVAD/MTX/AraC; Cyclophosphamide/Vincristine/Doxorubicin/Dexamethasone Alternating with High-Dose
Methotrexate/Cytarabine; Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Alternating
with Cytarabine/Methotrexate Regimen; HyperCVAD-HD MTX AraC Regimen;
NCIt related terms : HyperCVAD/HD MTX AraC Regimen; Hyper-CVAD/MA;
NCIt definition : A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone,
administered on a hyperfractionated schedule, alternating with high-dose cytarabine
and methotrexate, that can be used in the treatment of acute lymphoblastic leukemia
(ALL) and certain types of non-Hodgkin lymphoma (NHL), including Burkitt lymphoma,
and blastic plasmacytoid dendritic cell neoplasm (BPDCN).;